Missouri community healthcare centers face 340B uncertainty
While large hospitals and pharmaceutical manufacturers battle over drug costs, Missouri community health centers see themselves as collateral damage. Section 340B of the 1992 Publi…
While large hospitals and pharmaceutical manufacturers battle over drug costs, Missouri community health centers see themselves as collateral damage. Section 340B of the 1992 Publi…